Status | Study |
Completed |
Study Name: Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk Condition: Hyperoxaluria Date: 2015-03-26 Interventions: Dietary Supplement: Aloe vera with cactus |
Completed |
Study Name: Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria Condition: Hyperoxaluria Nephrolithiasis Date: 2014-11-10 Interventions: Drug: ALLN-177 ALLN-177 is orally administered oxalate decarboxylase (OxDc). The goal of oral therapy wi |
Recruiting |
Study Name: Primary Hyperoxaluria Mutation Genotyping/Phenotyping Condition: Primary Hyperoxaluria Date: 2014-09-16 Interventions: Other: Genetic Analysis We will draw one tube of blood from your arm to obtain white blood cells. These |
Active, not recruiting |
Study Name: Hydroxyproline Influence on Oxalate Metabolism Condition: Hyperoxaluria Date: 2013-12-19 Interventions: Drug: Hydroxyproline and Leucine Subjects will be infused with 13C5-hydroxyproline and 2H3-leucine for 6 |
Completed |
Study Name: Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria Condition: Primary Hyperoxaluria Date: 2013-12-11 Interventions: Biological: Oxabact OC5 capsules |
Recruiting |
Study Name: Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis Condition: Primary Hyperoxaluria Date: 2013-11-20 Interventions: Biological: Oxalobacter formigenes The dose will be (not less than) NLT ≥1E+09 colony forming unit |
Completed |
Study Name: Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate Condition: Primary Hyperoxaluria Type I Date: 2011-01-20 Interventions: Drug: Vitamin B 6 Oral solution of pyridoxal phosphate start with 5mg per kg body weight per day in two |
Completed |
Study Name: Oxazyme in Patients With Hyperoxaluria Condition: Hyperoxaluria Date: 2010-05-14 Interventions: Drug: Oxazyme Oxazyme (registered trademark) is a non-syst |
Completed |
Study Name: Phase 2/3 Oxabact Study Condition: Primary Hyperoxaluria Date: 2009-12-18 Interventions: Biological: Oxalobacter formigenes |
Withdrawn |
Study Name: International Registry for Primary Hyperoxaluria Condition: Primary Hyperoxaluria Nephrocalcinosis Date: 2009-04-02 |